For the Inventor, By the Inventor

Enter assignee name

Hetero Drugs Limited

USPTO Granted Patents = 45

EPO Patents = 8

Forward Citations = 64

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Bandi Parthasaradhi Reddy (35 out of 96 patents)

Kura Rathnakar Reddy (35 out of 94 patents)

Dasari Muralidhara Reddy (34 out of 73 patents)

4. Rapolu Raji Reddy (31 out of 50 patents)

5. Kesireddy Subash Chander Reddy (11 out of 24 patents)

6. Reddy Bandi Parthasaradhi (10 out of 10 patents)

7. Reddy Rapolu Raji (10 out of 10 patents)

8. Reddy Dasari Muralidhara (10 out of 10 patents)

9. Reddy Kura Rathnakar (10 out of 10 patents)

10. Reddy Kesireddy Subash Chander (7 out of 7 patents)

11. Thungathurthy Srinivas Rao (2 out of 2 patents)

12. Raji Reddy (2 out of 2 patents)

13. Dandamudi Satish Kumar (2 out of 2 patents)

14. Nagabelli Murali (2 out of 3 patents)

15. Jennepalli Sreenu (1 out of 6 patents)

Core Competencies:

Erlotinib

Polymorphs

Efavirenz

Stereoselective Synthesis

Benzimidazole Sulfoxides

Esomeprazole

Nebivolol

Donepezil Hydrochloride

Sertraline

Oseltamivir

Cefixime

Dorzolamide Hydrochloride

45 patents: Sort by Forward Citations

1. 8669265 - Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B (2014-03-11),

2. 8471012 - Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B (2013-06-25),

3. 8466279 - Polymorphs of efavirenz (2013-06-18),

4. 8389531 - Process for erlotinib hydrochloride (2013-03-05),

5. 8361507 - Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan (2013-01-29),

6. 8242267 - Polymorphs of efavirenz (2012-08-14),

7. 8227431 - Nucleoside derivatives (2012-07-24),

8. 8173817 - Stereoselective synthesis of benzimidazole sulfoxides (2012-05-08),

9. 8106210 - Polymorphs of esomeprazole salts (2012-01-31),

10. 7947840 - Process for preparation of enantiomerically pure esomeprazole (2011-05-24),

11. 7928241 - Stereoselective synthesis of benzimidazole sulfoxides (2011-04-19),

12. 7928240 - Process for preparation of substituted sulfoxides (2011-04-19),

13. 7858812 - Process for isolation of desired isomers of nebivolol intermediates (2010-12-28),

14. 7834027 - Gemifloxacin process and polymorphs (2010-11-16),

15. 7772438 - Process of making sertraline form I (2010-08-10),

Hetero Drugs Limited is one of India's leading generic pharmaceutical companies, specializing in the development, manufacturing, and marketing of high-quality and affordable pharmaceutical products. With a wide range of therapeutic categories and a strong global presence, Hetero Drugs Limited is committed to improving access to healthcare and enhancing the quality of life for people around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

45 Patents

#1 in

#41 in India

#14,974 in the World

Hetero Drugs Limited

Forward Citations = 64

26 inventors:

Bandi Parthasaradhi Reddy (35 out of 96 patents)

Kura Rathnakar Reddy (35 out of 94 patents)

Dasari Muralidhara Reddy (34 out of 73 patents)

4. Rapolu Raji Reddy (31 out of 50 patents)

5. Kesireddy Subash Chander Reddy (11 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…